Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof Auricchio showed compelling data from the MILOS study examining the use of CRT in AF patients. It is apparent that Av nodal ablation is required in the majority of cases to ensure optimal benefit from CRT. In the group with a pace and ablate strategy symptomatic improvement, reversed remodelling and survival were comparable or better than in the SR group receiving CRT.
Whilst current trials have generally recruited patients younger than the normal heart failure population, Dr Lamp observed the potential needs and benefits of CRT in the more elderly group. On reviewing the data from the Italian registry and her own data from Bad Oeynhausen, Dr Lamp showed that the symptomatic benefit was equal in the elderly group compared with the younger population. The impact on survival was less marked as would be expected provoking a discussion on the appropriatness of CRT-D in this population.
The role of CRT-D v CRT-P was taken up by Dr Lozano. He showed that whilst no formal study has adequately addressed the issue the weight of evidence supports the additional benefit of the combined device.
Prof Blanc reviewed the potentially deleterious effect of right ventricular pacing on ventricular function and summarised the trials so far on upgrading existing devices. Although there is no randomised data the general opinion remains that in those with deteriorating function up grade to CRT should be considered.
© 2017 European Society of Cardiology. All rights reserved